Finance

Lists
Why is RNTX down 6.03%?
Dive Deeper
RNTX:NASDAQ
Rein Therapeutics Inc
$0.80
-6.03%
(-0.051) 1D
$0.79
-0.97% (-0.0078)
After hours
Closed: Oct 2, 4:00:00ā€ÆPM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNTX...
Open
$0.85
High
$0.86
Low
$0.78
Mkt. cap
69.24M
Avg. vol.
471.70K
Volume
480.88K
52-wk high
$2.18
52-wk low
$0.69
EPS
-$1.59
Beta
1.36
Shares outstanding
86.27M
No. of employees
10
Open
$0.85
High
$0.86
Low
$0.78
Mkt. cap
69.24M
Avg. vol.
471.70K
Volume
480.88K
52-wk high
$2.18
52-wk low
$0.69
EPS
-$1.59
Beta
1.36
Shares outstanding
86.27M
No. of employees
10
News stories
From web sources and news partners
About Rein Therapeutics Inc
CEO-
Employees10
Founded2001
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitereintx.com
Analyst ratings
Based on 2 analysts giving stock ratings to RNTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RNTX in the last 3 months.
Highest
Current $0.80
$8.00 (+899.13%)
Average
$6.00 (+649.34%)
Lowest
$4.00 (+399.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Maintained
$8.00
+899.1%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$4.00
+399.6%
08/17/2026
Kemp Dolliver
Brookline Capital Markets
Hold
Downgraded
-
-
01/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.68M
2.00M
3.07M
3.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.81M
1.96M
2.16M
2.44M
Operating expense
5.49M
3.96M
5.23M
6.08M
Total operating expenses
5.49M
3.96M
5.23M
6.08M
Operating income
-5.49M
-3.96M
-5.23M
-6.08M
Other non operating income
-89.00K
-20.00K
-608.00K
-299.00K
EBT including unusual items
-5.58M
-32.68M
-5.84M
-6.38M
EBT excluding unusual items
-5.58M
-3.98M
-5.84M
-6.38M
Income tax expense
-
-712.00K
-
-
Effective tax rate
-
2.18%
-
-
Other operating expenses
-
-
-
-
Net income
-5.58M
-31.97M
-5.84M
-6.38M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.49M
-3.96M
-5.23M
-6.08M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps